Qingdao Harwars Biomedical Technology Co., Ltd. welcomes CNAS audit

From May 29 to May 30, 2021, a four-member audit team from the China National Accreditation Service for Conformity Assessment (CNAS) audited Qingdao Harwars Biomedical Technology Co., Ltd.

During the two-day period, the audit expert group conducted a comprehensive audit of Harwars Biotech from the laboratory quality management system, instruments and equipment, measurement traceability, quality control, personnel qualifications, etc.

While affirming the company's testing capabilities, the audit team also gave constructive suggestions on laboratory technical proficiency verification and quality supervision of new employees. This audit has a positive effect on the improvement of our company's inspection and testing capabilities, which can help the company improve service quality, expand social influence, and lay a solid foundation for faster adaptation to market changes.

Harwars will take this audit as an opportunity to continuously improve the system management level and on-site audit ability, give full play to the company's service advantages, and continue to provide excellent services to the society with professional technology and enthusiastic attitude.